Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacoepidemiology: the future.

H H Tilson1

  • 1Division of Epidemiology, Information, and Surveillance, Burroughs Wellcome Company, Research Triangle Park, NC 27709.

Drug Intelligence & Clinical Pharmacy
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeutics.

Clinical pharmacology and therapeutics·2007
Same author

Public health physicians: an endangered species.

American journal of preventive medicine·2001
Same author

Proactive safety surveillance.

Pharmacoepidemiology and drug safety·2001
Same author

Heralding a change: field action reports.

American journal of public health·2000
Same author

Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.

JAMA·1996
Same author

Implications for managed care organizations of the Merck and Medco consent.

Medical interface·1996

The future of pharmacoepidemiology is evolving, shaped by significant driving forces and key stakeholders. Responsible contributions, especially from the pharmaceutical industry, can positively influence its trajectory.

Area of Science:

  • Pharmacoepidemiology
  • Health policy
  • Pharmaceutical science

Background:

  • The field of pharmacoepidemiology is dynamic, with its future trajectory influenced by various external factors.
  • Understanding these influences is crucial for navigating the evolving landscape of drug safety and effectiveness research.

Purpose of the Study:

  • To review and analyze the major forces shaping the future agenda of pharmacoepidemiology.
  • To identify and discuss the roles of key actors involved in the field's development.

Main Methods:

  • Literature review and synthesis of current trends in pharmacoepidemiology.
  • Analysis of stakeholder influence and potential future directions.

Main Results:

Related Experiment Videos

  • Identified key driving forces impacting pharmacoepidemiology's future.
  • Assessed the roles and contributions of major actors within the field.
  • Highlighted the potential for positive influence through collaborative efforts.

    • Conclusions:

    • The future of pharmacoepidemiology is not predetermined and can be shaped by proactive engagement.
    • Responsible contributions from the pharmaceutical community are vital for advancing the field and ensuring public health.